Naringin abrogates osteoclastogenesis and bone resorption via the inhibition of RANKL-induced NF-κB and ERK activation.
about
Natural Products from Chinese Medicines with Potential Benefits to Bone HealthHistory, Global Distribution, and Nutritional Importance of Citrus FruitsThe role of small molecules in musculoskeletal regeneration.The role of small molecules in bone regeneration.Small molecule delivery through nanofibrous scaffolds for musculoskeletal regenerative engineeringThe Effects of Combined Treatment with Naringin and Treadmill Exercise on Osteoporosis in Ovariectomized RatsDoes dietary inulin affect biological activity of a grapefruit flavonoid-rich extract?The Function of Naringin in Inducing Secretion of Osteoprotegerin and Inhibiting Formation of Osteoclasts.Potential antiosteoporotic agents from plants: a comprehensive review.Naringin Stimulates Osteogenic Differentiation of Rat Bone Marrow Stromal Cells via Activation of the Notch Signaling PathwayNaringin ameliorates bone loss induced by sciatic neurectomy and increases Semaphorin 3A expression in denervated bone.Therapeutic potentials of naringin on polymethylmethacrylate induced osteoclastogenesis and osteolysis, in vitro and in vivo assessments.Nitidine chloride prevents OVX-induced bone loss via suppressing NFATc1-mediated osteoclast differentiation.Massive elimination of multinucleated osteoclasts by eupatilin is due to dual inhibition of transcription and cytoskeletal rearrangement.The adaptor protein p62/SQSTM1 in osteoclast signaling pathways.Technetium-99 conjugated with methylene diphosphonate inhibits receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis.Paclitaxel inhibits osteoclast formation and bone resorption via influencing mitotic cell cycle arrest and RANKL-induced activation of NF-κB and ERK.Eriodictyol Inhibits RANKL-Induced Osteoclast Formation and Function Via Inhibition of NFATc1 Activity.Inhibitory effects of eugenol on RANKL-induced osteoclast formation via attenuation of NF-κB and MAPK pathways.Molecular signaling mechanisms behind polyphenol-induced bone anabolism.Cyanidin Chloride inhibits ovariectomy-induced osteoporosis by suppressing RANKL-mediated osteoclastogenesis and associated signaling pathways.Novel antiosteoclastogenic activity of phloretin antagonizing RANKL-induced osteoclast differentiation of murine macrophages.Prevention and Treatment of Osteoporosis Using Chinese Medicinal Plants: Special Emphasis on Mechanisms of Immune Modulation.Bone Health and Natural Products- An Insight
P2860
Q26765485-025E368E-9C2C-4FC9-84E3-9A53212162C6Q29541428-F47EFC79-F799-468B-93BF-2E68F1871561Q34346326-4B977165-E02E-427E-8E27-788E6E828D19Q34991901-0751432B-C505-47C9-A6AE-ED841E40DD3EQ35836180-F34F9FA6-845B-4A70-AD14-23FB133BEA58Q35936071-14D1C6AD-656F-478E-97E3-64641F8AF7D0Q36023860-8DE804D1-5011-4E46-860D-7DEF85E0EDB5Q36537771-80B730BF-F6E2-4703-8F28-89A304333058Q36550932-40263D56-50CC-4CF1-BCA2-B714AB38BA8DQ36742024-C3C1EA1A-9BED-4061-ABEE-C5A8A231D3F5Q36830353-4DCE5B1E-5559-4F57-848A-F95FFBC64673Q37396554-A7AA76BC-D771-4FED-828E-D1E844BC99B6Q37399717-78087CA7-71DA-4CC0-918B-B60DC119782DQ37720538-1A9FCD50-EB22-46C4-AAB3-381CF8D6CA72Q37973113-53242F02-D16F-4895-A1A5-7FE3A22D6AC9Q39271170-052F0F9C-E30E-4535-BE51-822EB29F3AF8Q39451512-FA8605BE-2D28-4083-9839-A439204DA46CQ40120415-682B7B24-4BBB-42B7-9754-032F1F4C09F8Q46145950-608B786D-949C-499C-8D5F-20C4E616CBB0Q47130932-27997487-0B34-4B9A-BEED-66469228CF05Q47995224-9A85D2BD-D7A6-4240-9B58-D6E96EDFE2B4Q53371739-4662C868-B044-4F08-B483-A7456F9E0704Q55410884-4BBAB339-A7F3-4EA0-942A-901BFCF9489DQ57072931-F52F7C01-76BF-40FE-8597-8E9B3C859D67
P2860
Naringin abrogates osteoclastogenesis and bone resorption via the inhibition of RANKL-induced NF-κB and ERK activation.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Naringin abrogates osteoclasto ...... uced NF-κB and ERK activation.
@en
Naringin abrogates osteoclasto ...... uced NF-κB and ERK activation.
@nl
type
label
Naringin abrogates osteoclasto ...... uced NF-κB and ERK activation.
@en
Naringin abrogates osteoclasto ...... uced NF-κB and ERK activation.
@nl
prefLabel
Naringin abrogates osteoclasto ...... uced NF-κB and ERK activation.
@en
Naringin abrogates osteoclasto ...... uced NF-κB and ERK activation.
@nl
P2093
P2860
P1433
P1476
Naringin abrogates osteoclasto ...... uced NF-κB and ERK activation.
@en
P2093
Estabelle S M Ang
Honghui Chen
Ming H Zheng
Xiaohong Yang
P2860
P304
P356
10.1016/J.FEBSLET.2011.07.046
P407
P577
2011-08-06T00:00:00Z